OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
416358

Intai Technology Corp

Medical Equipment, Supplies & DistributionVerified

Intai Technology Corp has a debt-to-equity ratio of 0.53 and a current ratio of 2.13, indicating a moderate level of leverage and strong short-term liquidity. The company's liquidity position is supported by a cash and equivalents balance of 233.7 million TWD, although this is offset by long-term debt of 1.43 billion TWD, resulting in a net cash position that is negative after subtracting total debt. The company's profitability is reflected in a return on equity (ROE) of 9.21% and a return on assets (ROA) of 5.15%. These figures suggest that Intai is generating returns above the industry median for ROE and ROA, which are key metrics for evaluating performance in the medical equipment sector. Intai's revenue is concentrated in the domestic market and overseas markets such as the Americas, Europe, and the rest of Asia. The company does not disclose specific revenue by segment or geography, but its distribution strategy suggests a diversified geographic exposure. This diversification may help mitigate regional economic risks. The company's growth trajectory is supported by a strong operating cash flow of 458.69 million TWD and a free cash flow of 60.17 million TWD. While capital expenditures were negative at -184.80 million TWD, this may reflect a reduction in investment or a shift in capital allocation strategy. The company's revenue of 2.41 billion TWD indicates a stable financial position. The risk assessment for Intai Technology Corp highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to fund operations or investments without external financing. However, the low dilution risk suggests that the company is not currently issuing shares at a rate that would significantly dilute existing shareholders. Recent events for Intai Technology Corp include the latest financial results, which show a net income of 249.60 million TWD and an operating income of 286.13 million TWD. The company's gross profit of 1.07 billion TWD indicates strong cost control and pricing power in its product lines.

30-day price · 4163+15.00 (+14.6%)
Low$94.40High$118.00Close$118.00As of15 May, 00:00 UTC
Profile
CompanyIntai Technology Corp
Ticker4163.TWO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Intai Technology Corp is a Taiwan-based manufacturer of precision metal parts for medical equipment, including abdomen-open surgery and minimally invasive surgery instrument parts, laparotomy instrument parts, spine nails, bone nails, bone plates, and dental implants, distributing its products in the domestic market and to overseas markets such as the Americas, Europe, and the rest of Asia.

Classification. Intai Technology Corp is classified under the industry "Medical Equipment, Supplies & Distribution" within the business sector "Healthcare Services & Equipment" and economic sector "Healthcare," with a classification confidence of 0.92.

Intai Technology Corp has a debt-to-equity ratio of 0.53 and a current ratio of 2.13, indicating a moderate level of leverage and strong short-term liquidity. The company's liquidity position is supported by a cash and equivalents balance of 233.7 million TWD, although this is offset by long-term debt of 1.43 billion TWD, resulting in a net cash position that is negative after subtracting total debt. The company's profitability is reflected in a return on equity (ROE) of 9.21% and a return on assets (ROA) of 5.15%. These figures suggest that Intai is generating returns above the industry median for ROE and ROA, which are key metrics for evaluating performance in the medical equipment sector. Intai's revenue is concentrated in the domestic market and overseas markets such as the Americas, Europe, and the rest of Asia. The company does not disclose specific revenue by segment or geography, but its distribution strategy suggests a diversified geographic exposure. This diversification may help mitigate regional economic risks. The company's growth trajectory is supported by a strong operating cash flow of 458.69 million TWD and a free cash flow of 60.17 million TWD. While capital expenditures were negative at -184.80 million TWD, this may reflect a reduction in investment or a shift in capital allocation strategy. The company's revenue of 2.41 billion TWD indicates a stable financial position. The risk assessment for Intai Technology Corp highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to fund operations or investments without external financing. However, the low dilution risk suggests that the company is not currently issuing shares at a rate that would significantly dilute existing shareholders. Recent events for Intai Technology Corp include the latest financial results, which show a net income of 249.60 million TWD and an operating income of 286.13 million TWD. The company's gross profit of 1.07 billion TWD indicates strong cost control and pricing power in its product lines.
Key takeaways
  • Intai Technology Corp has a strong short-term liquidity position with a current ratio of 2.13.
  • The company's ROE of 9.21% and ROA of 5.15% indicate solid profitability relative to industry benchmarks.
  • Intai's revenue is distributed across domestic and international markets, suggesting a diversified geographic exposure.
  • The company's negative net cash position after subtracting total debt may pose a liquidity risk.
  • Intai's low dilution risk suggests that the company is not currently issuing shares at a rate that would significantly dilute existing shareholders.
  • The company's operating cash flow of 458.69 million TWD supports its financial stability and operational flexibility.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$2.41B
Gross profit$1.07B
Operating income$286.1M
Net income$249.6M
R&D
SG&A
D&A
SBC
Operating cash flow$458.7M
CapEx-$184.8M
Free cash flow$60.2M
Total assets$4.85B
Total liabilities$2.14B
Total equity$2.71B
Cash & equivalents$233.7M
Long-term debt$1.43B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.71B
Net cash-$1.20B
Current ratio2.1
Debt/Equity0.5
ROA5.1%
ROE9.2%
Cash conversion1.8%
CapEx/Revenue-7.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric4163Activity
Op margin11.9%13.3% medp25 5.9% · p75 13.5%below median
Net margin10.4%8.6% medp25 2.7% · p75 12.7%above median
Gross margin44.3%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-7.7%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity53.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Observations
IR observations
Last actual EPS5.09 TWD
Last actual revenue2,405,149,000 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 14:36 UTC#2ab8f7a2
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 14:40 UTCJob: c8bab3ab